Session 7
Clinical applications & Trial

Programm

• 15:30 – 15:42 10 Min. 2 Min.

  Influence of hyperthermia and radiotherapy treatment sequence on treatment time interval – A single hyperthermia center experience

  • Dr. med. Emanuel Stutz (Bern, CH)

   Clinical Applications & Trials
• 15:42 – 15:54 10 Min. 2 Min.

  Multiphase combined treatment for adults with GBM, including individualized multimodal immunotherapy: Single institute real world medical data in the light of clinical trial research data

  • Stefaan Van Gool (Köln, DE)

   Clinical Applications & Trials
• 15:54 – 16:06 10 Min. 2 Min.

  Safety, feasibility and efficacy of downstaging in locally advanced breast cancer with weekly chemotherapy and locoregional hyperthermia delivered using a 27.1 MHz capacitive system: Initial results from the ongoing RESHMART trial (ClinicalTrials.gov ID: NCT05099809)

  • Niloy Ranjan Datta Niloy Datta (Wardha, IN)

   Clinical Applications & Trials
• 16:06 – 16:18 10 Min. 2 Min.

  Clinical outcomes of re-irradiation using concurrent deep Hyperthermia and proton therapy for prostate cancer

  • Dr. Muhammad Hamza (Baltimore, US)

   Clinical Applications & Trials
• 16:18 – 16:30 10 Min. 2 Min.

  Radiotherapy combined with deep regional hyperthermia in elderly and frail patients with muscle invasive bladder cancer: Analysis of clinical outcomes and variation of temperature metrics

  • Adela Ademaj (Aarau, CH)

   Clinical Applications & Trials
• 16:30 – 16:42 10 Min. 2 Min.

  Correlation between invasive measured temperatures treatment outcome in high-risk soft tissue Sarcoma

  • Sultan Abdel-Rahman (Munich, DE)

   Quality Assurance, Image guidance, Thermometry, Treatment planning
• 16:42 – 16:54 10 Min. 2 Min.

  Modulated electro-hyperthermia added to chemoradiotherapy improves five year survival: Final results of a phase III randomised controlled trial

  • Dr Carrie Minnaar (Parktown, ZA)

   Clinical Applications & Trials